BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

167 related articles for article (PubMed ID: 32641734)

  • 21. Structural and functional roles of Daxx SIM phosphorylation in SUMO paralog-selective binding and apoptosis modulation.
    Chang CC; Naik MT; Huang YS; Jeng JC; Liao PH; Kuo HY; Ho CC; Hsieh YL; Lin CH; Huang NJ; Naik NM; Kung CC; Lin SY; Chen RH; Chang KS; Huang TH; Shih HM
    Mol Cell; 2011 Apr; 42(1):62-74. PubMed ID: 21474068
    [TBL] [Abstract][Full Text] [Related]  

  • 22. E1B-55K-Mediated Regulation of RNF4 SUMO-Targeted Ubiquitin Ligase Promotes Human Adenovirus Gene Expression.
    Müncheberg S; Hay RT; Ip WH; Meyer T; Weiß C; Brenke J; Masser S; Hadian K; Dobner T; Schreiner S
    J Virol; 2018 Jul; 92(13):. PubMed ID: 29695423
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Stress-dependent Daxx-CHIP interaction suppresses the p53 apoptotic program.
    McDonough H; Charles PC; Hilliard EG; Qian SB; Min JN; Portbury A; Cyr DM; Patterson C
    J Biol Chem; 2009 Jul; 284(31):20649-59. PubMed ID: 19465479
    [TBL] [Abstract][Full Text] [Related]  

  • 24. SUMO-mediated inhibition of glucocorticoid receptor synergistic activity depends on stable assembly at the promoter but not on DAXX.
    Holmstrom SR; Chupreta S; So AY; Iñiguez-Lluhí JA
    Mol Endocrinol; 2008 Sep; 22(9):2061-75. PubMed ID: 18562626
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Cytoplasmic sumoylation by PIAS-type Siz1-SUMO ligase.
    Takahashi Y; Iwase M; Strunnikov AV; Kikuchi Y
    Cell Cycle; 2008 Jun; 7(12):1738-44. PubMed ID: 18583943
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Characterizing the N- and C-terminal Small ubiquitin-like modifier (SUMO)-interacting motifs of the scaffold protein DAXX.
    Escobar-Cabrera E; Okon M; Lau DK; Dart CF; Bonvin AM; McIntosh LP
    J Biol Chem; 2011 Jun; 286(22):19816-29. PubMed ID: 21383010
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Functional modulation of parkin through physical interaction with SUMO-1.
    Um JW; Chung KC
    J Neurosci Res; 2006 Nov; 84(7):1543-54. PubMed ID: 16955485
    [TBL] [Abstract][Full Text] [Related]  

  • 28. SUMO-1 modification and its role in targeting the Ran GTPase-activating protein, RanGAP1, to the nuclear pore complex.
    Matunis MJ; Wu J; Blobel G
    J Cell Biol; 1998 Feb; 140(3):499-509. PubMed ID: 9456312
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Ginkgoic acid impedes gastric cancer cell proliferation, migration and EMT through inhibiting the SUMOylation of IGF-1R.
    Liu D; Li Z; Yang Z; Ma J; Mai S
    Chem Biol Interact; 2021 Mar; 337():109394. PubMed ID: 33508304
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Molecular Characterization and Functional Analysis of Annulate Lamellae Pore Complexes in Nuclear Transport in Mammalian Cells.
    Raghunayakula S; Subramonian D; Dasso M; Kumar R; Zhang XD
    PLoS One; 2015; 10(12):e0144508. PubMed ID: 26642330
    [TBL] [Abstract][Full Text] [Related]  

  • 31. SUMO and Nucleocytoplasmic Transport.
    Ptak C; Wozniak RW
    Adv Exp Med Biol; 2017; 963():111-126. PubMed ID: 28197909
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Enzymes of the SUMO modification pathway localize to filaments of the nuclear pore complex.
    Zhang H; Saitoh H; Matunis MJ
    Mol Cell Biol; 2002 Sep; 22(18):6498-508. PubMed ID: 12192048
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Identification of a SUMO-binding motif that recognizes SUMO-modified proteins.
    Song J; Durrin LK; Wilkinson TA; Krontiris TG; Chen Y
    Proc Natl Acad Sci U S A; 2004 Oct; 101(40):14373-8. PubMed ID: 15388847
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The insulin-sensitive glucose transporter, GLUT4, interacts physically with Daxx. Two proteins with capacity to bind Ubc9 and conjugated to SUMO1.
    Lalioti VS; Vergarajauregui S; Pulido D; Sandoval IV
    J Biol Chem; 2002 May; 277(22):19783-91. PubMed ID: 11842083
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The nucleoporin RanBP2 has SUMO1 E3 ligase activity.
    Pichler A; Gast A; Seeler JS; Dejean A; Melchior F
    Cell; 2002 Jan; 108(1):109-20. PubMed ID: 11792325
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Perturbation of SUMOlation enzyme Ubc9 by distinct domain within nucleoporin RanBP2/Nup358.
    Saitoh H; Pizzi MD; Wang J
    J Biol Chem; 2002 Feb; 277(7):4755-63. PubMed ID: 11709548
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Nucleolar and spindle-associated protein 1 (NUSAP1) interacts with a SUMO E3 ligase complex during chromosome segregation.
    Mills CA; Suzuki A; Arceci A; Mo JY; Duncan A; Salmon ED; Emanuele MJ
    J Biol Chem; 2017 Oct; 292(42):17178-17189. PubMed ID: 28900032
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Modification of Daxx by small ubiquitin-related modifier-1.
    Jang MS; Ryu SW; Kim E
    Biochem Biophys Res Commun; 2002 Jul; 295(2):495-500. PubMed ID: 12150977
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Regulation of Wnt signaling by the nuclear pore complex.
    Shitashige M; Satow R; Honda K; Ono M; Hirohashi S; Yamada T
    Gastroenterology; 2008 Jun; 134(7):1961-71, 1971.e1-4. PubMed ID: 18439914
    [TBL] [Abstract][Full Text] [Related]  

  • 40. DAXX inhibits cancer stemness and epithelial-mesenchymal transition in gastric cancer.
    Wu C; Ding H; Wang S; Li Y; Liu SB; Wang X; Zheng J; Xue T; Amin HM; Song YH; Zhou J
    Br J Cancer; 2020 May; 122(10):1477-1485. PubMed ID: 32203224
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.